Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

PDE IV inhibitor from Almirall does not stimulate gastric acid secretion in rats

Nov. 12, 1997

Dura submits NDA for Albuterol Spiros

Nov. 12, 1997

Zeneca selects new HLE inhibitor for clinical development

Nov. 6, 1997

Chiroscience develops new TNF/PDE IV inhibitors

Nov. 4, 1997

HMR claims dual H1/NK1 antagonists for allergic/inflammatory disorders

Nov. 4, 1997

rPAF-AH proceeds to phase II for asthma

Oct. 31, 1997

HMR reports dual H1/NK1 receptor antagonists

Oct. 30, 1997

Spotlight on tryptase inhibitors for asthma

Oct. 28, 1997

SciClone presents promising preclinical data for CPX at CF conference

Oct. 27, 1997

Potent, topically active glucocorticoid from RPR shows potential for bronchial asthma

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...